N-(2-aminophenyl)-4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzamide

ID: ALA5282062

Max Phase: Preclinical

Molecular Formula: C27H24N4O5

Molecular Weight: 484.51

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccccc1NC(=O)c1ccc(COc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)cc1

Standard InChI:  InChI=1S/C27H24N4O5/c28-20-5-1-2-6-21(20)29-25(33)17-10-8-16(9-11-17)15-36-23-7-3-4-18-19(23)14-31(27(18)35)22-12-13-24(32)30-26(22)34/h1-11,22H,12-15,28H2,(H,29,33)(H,30,32,34)

Standard InChI Key:  RDQXAQYEABCNQH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
   -0.7132   -1.4611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0013   -1.0488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7133   -1.4608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7133   -2.2861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0031   -2.6981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7132   -2.2898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4280   -2.7025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4280   -3.5278    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1429   -2.2898    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8575   -2.7025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8578   -3.5279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5708   -3.9387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2858   -3.5259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2874   -2.7047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5754   -2.2881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5754   -1.4627    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4281   -1.0481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1429   -1.4608    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8576   -1.0481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8578   -0.2227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5708    0.1879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2858   -0.2247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2874   -1.0460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5754   -1.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4006    0.9928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2469    0.3283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5824    1.0796    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1697    1.7944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3443    1.7944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9316    2.5091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3444    3.2239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1697    3.2239    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5824    2.5092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9316    3.9387    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4077    2.5092    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9841    1.5765    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 10 15  1  0
 15 16  1  0
  3 17  1  0
 17 18  1  0
 18 19  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 23 22  1  0
 24 23  2  0
 19 24  1  0
 21 25  1  0
 20 26  1  0
 26 27  1  0
 27 25  1  0
 28 27  1  0
 28 29  1  0
 30 29  1  0
 31 30  1  0
 32 31  1  0
 28 33  1  0
 33 32  1  0
 31 34  2  0
 33 35  2  0
 25 36  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5282062

    ---

Associated Targets(Human)

MM1.S (1111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC3 Tclin Histone deacetylase 3 (3654 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 484.51Molecular Weight (Monoisotopic): 484.1747AlogP: 2.86#Rotatable Bonds: 6
Polar Surface Area: 130.83Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 11.61CX Basic pKa: 3.24CX LogP: 1.95CX LogD: 1.95
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.36Np Likeness Score: -0.46

References

1. Li D, Yu D, Li Y, Yang R..  (2022)  A bibliometric analysis of PROTAC from 2001 to 2021.,  244  [PMID:36274273] [10.1016/j.ejmech.2022.114838]

Source